Position in IQV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$20,227,235
+$3,922,759 QoQ
Shares Held
104,685
+9.5% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#149
of 1,082 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Focus Partners Wealth holds $898,220,753 across 20 Diagnostics & Research names. IQV ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
860,536 | $431,438,328 | |
| 2 | WAT |
Waters Corp /De/
|
485,602 | $182,120,174 | |
| 3 | DHR |
Danaher Corp /De/
|
725,093 | $138,115,714 | |
| 4 | DGX |
Quest Diagnostics Inc
|
163,327 | $34,617,157 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
61,904 | $32,588,741 | |
| 6 | A |
Agilent Technologies, Inc.
|
157,327 | $20,897,745 | |
| 7 | IQV |
Iqvia Holdings Inc.
This page
|
104,685 | $20,227,235 | |
| 8 | ILMN |
Illumina, Inc.
|
65,397 | $11,498,754 |
All Filings in IQV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,227,235 | 104,685 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $16,304,476 | 95,605 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,745,014 | 87,596 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,598,978 | 76,861 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,855,744 | 68,886 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,292,367 | 64,052 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $11,428,235 | 58,156 | Shares | Sole | 2025-05-20 | |
| 2024-09-30 | $1,392,672 | 5,877 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $984,464 | 4,656 | Shares | Sole | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||